The Billion-Dollar Startup

Spohalo has recently been incorporated in Singapore as the first biotech startup focused on spore-based microorganisms. 

The startup is continuously pursuing other natural health products and alternative approaches in dealing with certain diseases.

The founder's vision

Chairman, David Chan Pham


If antibiotics are considered one of the greatest inventions of the 20th century,

then pre-activated probiotics are one of the greatest inventions of the 21st century


Spohalo aims to become the first biotech startup in the world

to directly address and reduce the use of antibiotics and antibiotic resistance, categorized by the WHO as “one of the biggest threats to global health, food security and development today”.

Replacing antibiotics with probiotics would not only address antibiotic resistance but also fortify human health.

The founder’s vision is to bring microorganisms and apply biotechnology to all aspects of life in the 21st century, reaching beyond sectors of human health to agriculture, aquaculture, and even consumer products.